Saturday, September 4th, 2010
Special Session: Huntington, History and Art
| 08:30-08:50 |
|
An Individual Pilgrimage to Prague Christiane Lohkamp EHA (Stuttgart, Germany)
|
Plenary Session V: Scientific Presentations
| Chair: Christian Néri (Paris, France) | | | | Topic: Pathogenesis - Targets for Experimental Treatments in HD |
| 09:00-09:20 |
|
Stress Response and Proteostasis Rick Morimoto (Evanston, USA) |
| |
| 09:20-09:40 |
|
Sirtuins in Aging and Neurodegeneration Ruth Luthi-Carter (Lausanne, Switzerland) |
| |
| 09:40-10:00 |
|
Antisense Oligonucleotide Therapy for HD Don Cleveland (La Jolla, USA) |
| |
| 10:00-10:20 |
|
Is Huntingtin Also a Prion? Ronald Melki (Gif-sur-Yvette, France) |
| |
| 10:20-11:00 |
|
Tea/Coffee Break |
Plenary Session VI: Keynote Presentation
| Chair: Gillian Bates (London, UK) |
| |
| 11:00-12:00 |
|
Animal Models for HD William Yang (Los Angeles, USA) |
| |
| 12:30-14:00 |
|
Buffet Style Lunch |
| |
| 12:00-14:00 |
|
Poster Viewing & Guided Poster Tours
Chaired by Stephen Dunnett (Cardiff, UK), Raymund Roos (Leiden, The Netherlands) |
Short
Communications II:
| Chair: Sheila Simpson (Aberdeen, UK) |
| |
| 14:00-14:15 |
|
Autophagy
Modulatin: a Potential Therapeutic Approach for
HD Robi Meray / Mike Poole Link
Medicine (Cambridge, USA) | | |
| 14:15-14:30 | |
Developing RNAi Therapeutics
Targeting Huntingtin with Direct CNS Delivery Dinah Sah, Alnylam (Cambridge, USA) | | |
| 14:30-14:45 | |
Evaluation
of the therapeutic potential of NP03, a low-dose lithium microemulsion, in the YAC128 mouse model of Huntington
Disease
Mahmoud Pouladi (Vancouver, Canada) | | |
| 14:45-15:00 | |
Systematic
identification of single nucleotide polymorphisms that modulate the
age-at-onset of Huntington’s disease
Erich Wanker (Berlin,
Germany) | | | Plenary Session VII: Scientific Presentations
| Chair: Berry Kremer (Groningen, The Netherlands) |
| |
| Topic: Therapeutic Development Programme in HD |
| 15:00-15:20 |
|
When to Enter Human Clinical Trials? Ignacio Munoz-Sanjuan (Los Angeles, USA) |
| |
| 15:20-15:40 |
|
siRNAs for the Treatment of HD Neil Aronin (Boston, USA) |
| |
| 15:40-16:00 |
|
ACR-16 for the Treatment of HD Joakim Tedroff (Stockholm, Sweden) |
| |
| 16:00-16:20 |
|
DBS Surgical Trials in HD Jan Vesper (Düsseldorf, Germany) |
| |
| 16:20-17:00 |
|
Tea/Coffee Break |
| |
Sunday, September 5th, 2010
Breakfast Teaching Courses (parallel courses)
| 08:00-09:20 |
|
How and When to Diagnose HD
Sarah Tabrizi (London, UK),
Oliver Quarrell (Sheffield, UK) |
| |
| 08:00-09:20 |
|
How to Treat Huntington's Disease
Josef Priller (Berlin, Germany),
Raymund Roos (Leiden, The Netherlands) |
| |
| 08:00-09:20 |
|
Movement Disorders Phenomenology in HD Ralf Reilmann (Münster, Germany)
Ferdinando Squitieri (Pozzilli, Italy) |
| |
| 08:00-09:20 |
|
Psychiatric Disorders in HD for Non-Psychiatrists David Craufurd (Manchester, UK),
Erik van Duijn (Leiden, The Netherlands) |
| |
| 09:20-10:00 |
|
Tea/Coffee Break |
Plenary Session VIII: Scientific Presentations
| Chair: G. Bernhard Landwehrmeyer (Ulm, Germany) |
| |
| Topic: Tools and Outcome to Monitor Disease Progression and Response to Therapy |
| 10:00-10:20 |
|
Imaging Outcomes Rachel Scahill (London, UK) |
| |
| 10:20-10:40 |
|
Motor phenotype Outcomes Ralf Reilmann (Münster, Germany) |
| |
| 10:40-11:00 |
|
Cognitive Outcomes Anne-Catherine Bachoud-Lévi (Créteil, France) |
| |
| 11:00-11:20 |
|
How Disease Modelling Can Inform Trial Design John Warner (Princeton, USA) |
| |
| 11:20-12:00 |
|
Meeting Adjourn/Closing Remarks |
| |
| Afternoon |
|
Social Activities |
Programme Thursday and Friday
Please note:
Since the meeting starts on Friday morning at 08.30, we highly recommend that you plan to arrive
on Thursday, September 2nd, 2010.
Meals and refreshments will be provided during EHDN 2010 (i.e. from Friday until midday on Sunday;
Sunday lunch will not be included) free of charge. |